Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Equijost. 2020; 7(2): 83-90


Application of ARIMA and Artificial Neural Networks Models for Daily Cumulative confirmed Covid-19 Prediction in Nigeria

Shamsuddeen Suleiman, Muhammad Sani.




Abstract

Coronavirus 2019, commonly referred to as COVID-19, is a disease discovered in China towards the end of December 2019. This novel and highly infectious virus spreads rapidly across the globe. In Nigeria, as of June 2020, the cumulative number of COVID-19 cases reported was 25,694: out of this, 9746 cases were treated and 590 cases lost their lives. This research was aimed at comparing the prediction ability of ARIMA and ANN models. The aggregate COVID-19 cases reported in Nigeria was subjected to Box-Jenkins time series and Backpropagation gradient-based Artificial Neural Network Approaches for the prediction purpose. The data obtained from the Nigeria Centre for Disease Control (NCDC) was used. The data were identified to follow ARIMA (1, 2, 1) and were best trained by Bayesian Regularization Artificial Neural Network algorithm. The prediction performance of the two models were compared using RMSE, MAE and MAPE. The empirical results obtained show that the Artificial Neural Network model gives better predictions and forecasts over the ARIMA model.

Key words: COVID-19, Box-Jenkins, ARIMA, ANN, Backpropagation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.